- Home
- SJ vs NXTC Comparison
SJ vs NXTC Comparison
Compare SJ & NXTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SJ
- NXTC
- Stock Information
- Founded
- SJ 2011
- NXTC 2015
- Country
- SJ China
- NXTC United States
- Employees
- SJ N/A
- NXTC N/A
- Industry
- SJ EDP Services
- NXTC Biotechnology: Pharmaceutical Preparations
- Sector
- SJ Technology
- NXTC Health Care
- Exchange
- SJ Nasdaq
- NXTC Nasdaq
- Market Cap
- SJ 38.5M
- NXTC 31.6M
- IPO Year
- SJ N/A
- NXTC 2019
- Fundamental
- Price
- SJ $0.86
- NXTC $0.89
- Analyst Decision
- SJ
- NXTC Strong Buy
- Analyst Count
- SJ 0
- NXTC 2
- Target Price
- SJ N/A
- NXTC $4.00
- AVG Volume (30 Days)
- SJ 29.5K
- NXTC 218.5K
- Earning Date
- SJ 11-25-2024
- NXTC 11-07-2024
- Dividend Yield
- SJ N/A
- NXTC N/A
- EPS Growth
- SJ N/A
- NXTC N/A
- EPS
- SJ 0.16
- NXTC N/A
- Revenue
- SJ $205,406,515.00
- NXTC N/A
- Revenue This Year
- SJ $43.43
- NXTC N/A
- Revenue Next Year
- SJ N/A
- NXTC N/A
- P/E Ratio
- SJ $5.70
- NXTC N/A
- Revenue Growth
- SJ N/A
- NXTC N/A
- 52 Week Low
- SJ $0.66
- NXTC $0.87
- 52 Week High
- SJ $3.59
- NXTC $2.57
- Technical
- Relative Strength Index (RSI)
- SJ 40.81
- NXTC 22.88
- Support Level
- SJ $0.83
- NXTC $1.06
- Resistance Level
- SJ $0.98
- NXTC $1.21
- Average True Range (ATR)
- SJ 0.07
- NXTC 0.10
- MACD
- SJ -0.01
- NXTC -0.02
- Stochastic Oscillator
- SJ 23.83
- NXTC 5.21
About SJ Scienjoy Holding Corporation
Scienjoy Holding Corp is a show live streaming video entertainment social platform in China. The company operates a mobile live-streaming business by which it provides live-streaming entertainment from professional broadcasters to the end-users, allowing for the operation of live social video communities. It operates online live-streaming brands, with their respective websites & mobile apps, Showself, Lehai, & Haixiu, using Scienjoy's own mobile applications. Through the app, users can also view photos posted by broadcasters on their personal pages, leave comments, & engage in private chats with broadcasters. The users can also play simple, fun games using virtual currencies within the video rooms while watching the live streaming of a broadcaster. Geographically, it operates in PRC.
About NXTC NextCure Inc.
NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. The company's product candidates include; NC410 a fusion protein of LAIR-2, a fusion protein that, in combination with pembrolizumab, demonstrated early evidence of clinical activity in colorectal (CRC) and ovarian cancers, and LNCB74, an ADC that is directed to B7-H4, a clinically validated cancer target. The company is also seeking a partner for its other clinical programs such as NC525 and NC318 and its preclinical non-oncology programs NC605, for chronic bone diseases, and NC181, for Alzheimer's disease.